E. Karran

Physiology · 2000–2019

A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom E. Karran trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Holtzman

Who trusts E. Karran overall

  1. K. Sharma
  2. Oskar Hansson
  3. Scott J. Webster

Papers from E. Karran's perspective

Ordered by how strongly the researchers E. Karran trusts endorse each paper. Same corpus, a different order for every researcher.

  1. S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain
  2. Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo (Nature Medicine)
  3. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
  4. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. (Proceedings of the National Academy of Sciences of the United States of America)
  5. APOE Predicts Aβ but not Tau Alzheimer’s Pathology in Cognitively Normal Aging (Annals of Neurology)
  6. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease (Proceedings of the National Academy of Sciences of the United States of America)
  7. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. (Journal of Clinical Investigation)
  8. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo (Nature)
  9. Cerebrospinal Fluid Biomarker Signature in Alzheimer’s Disease Neuroimaging Initiative Subjects (Annals of Neurology)
  10. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans (Annals of Neurology)

Their papers